Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. netherlands antilles
  3. Equipment
Show results for
Products
Services
Software
Training
Applications

Companies


Refine by
Brands

  • icosavax

Icosavax Medical Equipment & Supplies In In Netherlands Antilles

4 equipment items found
Available In Netherlands AntillesNear Netherlands Antilles

Icosavax - Model IVX-A12 - RSV/hMPV Bivalent VLP Vaccine Candidate

Icosavax - Model IVX-A12 - RSV/hMPV Bivalent VLP Vaccine Candidate

Manufactured by:AstraZeneca   based inCambridge, UNITED KINGDOM
IVX-A12 is a bivalent combination of IVX-121 and IVX-241, a human metapneumovirus (hMPV) VLP vaccine candidate. IVX-A12 is being designed to target both RSV and hMPV in a single vaccine candidate. hMPV is being increasingly recognized as a major contributor to acute respiratory infection and pneumonia with rates of pneumonia (Clinics in Chest Medicine 2017) and hospitalization (JID 2012) similar ...
CONTACT SUPPLIER

Icosavax - Model IVX-411 - SARS-CoV-2 VLP Vaccine Candidate

Icosavax - Model IVX-411 - SARS-CoV-2 VLP Vaccine Candidate

Manufactured by:AstraZeneca   based inCambridge, UNITED KINGDOM
IVX-411 targets SARS-CoV-2, the coronavirus that causes COVID-19. Developed using cutting-edge structure-based design techniques at the Institute for Protein Design at the UW School of Medicine, IVX-411, our lead vaccine candidate for COVID-19, is a self-assembling protein nanoparticle that displays 60 copies of the SARS-CoV-2 spike (S) glycoprotein receptor-binding domain (RBD) in a highly ...
CONTACT SUPPLIER

Icosavax - Model IVX-121 - RSV VLP Vaccine Candidate

Icosavax - Model IVX-121 - RSV VLP Vaccine Candidate

Manufactured by:AstraZeneca   based inCambridge, UNITED KINGDOM
IVX-121 targets respiratory syncytial virus (RSV), a major cause of viral pneumonia for which no vaccine has been FDA approved. IVX-121 incorporates a stabilized prefusion F antigen licensed from NIAID/NIH (DS-Cav1; Science 2019). RSV F is known to undergo major structural changes that allow viral entry into the host cell, and during that process, critical protective epitopes are lost. Protein ...
CONTACT SUPPLIER

Icosavax - Model IVX-421 - SARS-CoV-2 Beta (B.1.351) Variant VLP Vaccine Candidate

Icosavax - Model IVX-421 - SARS-CoV-2 Beta (B.1.351) Variant VLP Vaccine Candidate

Manufactured by:AstraZeneca   based inCambridge, UNITED KINGDOM
Icosavax has initiated development of IVX-421, a SARS-CoV-2 vaccine candidate that incorporates an RBD antigen with critical mutations found in the SARS-CoV-2 beta ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT